Helix BioPharma Corp. Long-term Investment Intensity
Helix BioPharma Corp. long-term investment intensity. Helix BioPharma Corp. (HBP) has a Long-term Investment Intensity of 2.8% as of July 2011. Long-term investments of CA$692.00K represent 2.8% of total assets of CA$24.37 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read HBP current and long-term liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Helix BioPharma Corp. (2009–2011)
Long-term investment intensity of Helix BioPharma Corp. from 2009 to 2011. This chart shows how Helix BioPharma Corp.'s Long-term Investment Intensity has evolved across 3 annual periods from 2009 to 2011. As of July 2011, the intensity stands at 2.8%, reflecting long-term investments of CA$692.00K against total assets of CA$24.37 Million CAD.
Helix BioPharma Corp. Long-term Investment Intensity by Year (2009–2011)
Helix BioPharma Corp. long-term investment intensity by year from 2009 to 2011. The table below presents the year-by-year Long-term Investment Intensity for Helix BioPharma Corp. from 2009 to 2011, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Helix BioPharma Corp.'s balance sheet.
| Year | LT Investment Intensity | LT Investments (CAD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2011 | 2.8% | CA$692.00K | CA$24.37 Million | ▲ +0.4 pp |
| 2010 | 2.5% | CA$446.00K | CA$18.11 Million | ▲ +2.2 pp |
| 2009 | 0.3% | CA$56.00K | CA$19.32 Million | — |